Esophageal basaloid carcinoma

Summary

Esophageal basaloid carcinoma (MONDO:0004093) is a cancer. A subtype of basaloid squamous cell carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	esophageal basaloid carcinoma
Mondo ID	MONDO:0004093
DOID	DOID:7051
NCIT	C7032
UMLS	C1333443
MedGen	232156
GARD	0023816
Is cancer (heuristic)	yes

Also known as: basaloid squamous carcinoma of esophagus · basaloid squamous carcinoma of oesophagus · basaloid squamous carcinoma of the oesophagus · esophageal basaloid cancer · esophageal basaloid carcinoma

Disease family

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › epithelial neoplasm › squamous cell neoplasm › squamous cell carcinoma › basaloid squamous cell carcinoma › esophageal basaloid carcinoma

Related subtypes (6): cervical basaloid carcinoma, basaloid carcinoma of the penis, vulvar basaloid squamous cell carcinoma, skin basaloid carcinoma, thymic basaloid carcinoma, anus basaloid carcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.